Lokman Hekim University Ankara Hospital
Lokman Hekim University Ankara Hospital
Turkey, Ankara
Bahri Gok
19 years of experience
Clinic is certified :
| Turkey | Austria | Spain | |
| Operation by doctor's recommendation | from $145 | from $3,500 | from $3,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Operation by doctor's recommendation upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Operation by doctor's recommendation and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Operation by doctor's recommendation journey.
Day 1: Arrival
Day 2: Pre-operation
Day 3: The Operation
Day 4: Post-operation
Week 1-2: Rehabilitation
Week 3-4: Return to Normal Activities
Week 5-6: Full Recovery
Please note that this is a general guideline and individual cases may vary.
Dr. Bahri Gok is a urologist at LHÜ Ankara Hospital (2024–). He earned his MD from Selçuk University (2001–2007). He completed his urology residency at Ankara Atatürk Training and Research Hospital (2008–2013). He served in the Department of Urology at Ankara Yıldırım Beyazıt University as Assistant Professor (2017–2020) and Associate Professor (2020–2023). He was the Urology Training Supervisor at Ankara City Hospital (2019–2023).
Accreditations and training include da Vinci Console Surgeon training at IRCAD (05.11.2019). He attended the EAU Robotic Urology Section meeting (2018) and the National Endourology Congresses (2013, 2015, 2019). He completed a biostatistics course (2018) and holds a Laboratory Animal Use certificate (2012). Memberships: SIU; Turkish Urology Association; Society of Urological Surgery; Eurasian Uro-oncology Association.
Achievements include serving as an investigator in a 2024 international Phase 2 trial of adjuvant V940 (mRNA‑4157) plus pembrolizumab for high‑risk muscle‑invasive urothelial carcinoma. He supervised a 2020 doctoral thesis on robot‑assisted radical prostatectomy. He received Best Poster awards at EAU (Latvia, 2015) and at the Eurasian Uro‑oncology and SIU meetings (2019).